EP4054582
THERAPEUTIC COMBINATIONS OF ACALABRUTINIB AND CAPIVASERTIB TO TREAT B-CELL MALIGNANCIES
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
30.10.2020EP published:
3.9.2025EP application number:
20800617.1
EPO information:
European Patent Register
Max expiry date:
29.10.2040
Title in English:
THERAPEUTIC COMBINATIONS OF ACALABRUTINIB AND CAPIVASERTIB TO TREAT B-CELL MALIGNANCIESLanguage of the patent:
English
Timeline
Today
30.10.2020EP application
3.9.2025EP Publication
Owner
Name:
Astrazeneca ABAddress:
151 85 Södertälje, SE
Inventor
Name:
DRY, HannahAddress:
Wilmington, Delaware 19850-5437, US
Name:
WILLIS, BrandonAddress:
Wilmington, Delaware 19850-5437, US
Name:
BLOECHER, AndrewAddress:
Wilmington, Delaware 19850-5437, US
Name:
METTETAL, JeromeAddress:
Wilmington, Delaware 19850-5437, US
Priority
Number:
201962930208 PDate:
4.11.2019Country:
US
Classification
Categories:
A61K 31/4985, A61K 31/519, A61P 35/00